TGFB1 and osteosarcoma: Further, the inhibitory effects of TGF-β inhibitor, SB431542 on cell invasion in osteosarcoma cells was weakened by TRIM66 overexpression (Supplementary Figure S2), which suggested TRIM66 may promote cell invasion partially by activating TGF-β pathway.